Information Provided By: 
Fly News Breaks for August 12, 2015
MDCO
Aug 12, 2015 | 07:39 EDT
RBC Capital believes that Phase I data,on The Medicines Co's ALN-PCSsc drug could show longer duration of activity than existing anti-PCSK9 drugs. If data on the drug, due to be presented August 30, is positive, the shares could rise 20%-30%. If the data is negative, the stock's decline would be "limited," according to the firm.
News For MDCO From the Last 2 Days
There are no results for your query MDCO
